SEC Form 3 · accession 0000914760-15-000271
Akari Therapeutics Plc · AKTX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
James Hill
Director · 10% Owner
Period of report
Sep 18, 2015
Accepted (ET)
Sep 23, 2015 · 10:37 am EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001541157
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Ordinary SharesF1 | holding | — | — | — | 722,345,600 | I | See Footnote |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Represents the entire holdings of RPC Pharma Limited. The reporting person disclaims beneficial ownership except to the extend of his actual pecuniary interest in such shares.